Navigation Links
Prominence UFLC

C conclusively results in significantly faster analysis with high reliability.




Flexibility
Prominence UFLC can be used for a broad range of applications, including conventional HPLC, or set up as a column switching system or a semi-preparative system. The wide flow rate range (100nL-10mL/min) and high delivery resolution of the pump (3.7nL), combined with the reproducibility of the autosampler, offer superior performance for both UFLC and conventional LC, so usage is not restricted to UFLC analyses.

Furthermore, Prominence UFLC excels as a front end for MS and MS/MS. Figure 4 shows high-speed, accurate MSn analysis of Opioid Antagonist and its metabolites utilizing the LCMS-IT-TOF (Shimadzu). With the auto MSn function, the IT-TOF with Prominence UFLC produced MS/MS data with high accuracy in a 2-minute cycle time. High-speed/high-accurate MSn offers identification of target compounds in the field of impurity analysis, biomarker search and metabolite profiling.




Conclusion
Prominence UFLC with XR-ODS columns enables users to shorten analysis time drastically and easily without extremely high pressure, while maintaining the high separation efficiency of conventional columns and system performance features such as reproducibility, carryover and durability. Prominence UFLC is applicable for a wide range of customers as a highly reliable, and flexible, fast LC system that does not require specialized components.


Q&A: Fast HPLC

Q: Is h
'"/>

Source:


Page: All 1 2 3 4 5 6 7 8

Related biology technology :

1. Evaluation of FlashPlate in a Helicase Assay
2. Accurate Evaluation of the Finnigan Surveyor Autosampler Performance using a Deferred Standard
3. Practical Aspects of Evaluation of Chromatographic Data in Size Exclusion Chromatography
4. Advancing the quality control methodology to assess isolated total RNA and generated fragmented cRNA
5. Flow cytometric analysis of human primary cells using the Agilent 2100 bioanalyzer and on-chip staining
6. Development of a Multiplex Bead-Based Assay for Antibody Screening of a Nonhuman Primate Colony on the Bio-Plex System
7. Using the Agilent 2100 bioanalyzer for quality control of protein samples prior to MS-analysis
8. Is Z factor the best assessment for the quality of cellular assays delivering higher content?
9. Quality control of antibodies using the 2100 bioanalyzer and the Protein 200 Plus assay
10. Quality assurance of RNA derived from laser microdissected tissue samples obtained by the PALM MicroBeam System using the RNA 6000 Pico LabChip kit.
11. Analysis of urine and seawater samples by ultrasonic nebulization with a high resolution ICP spectrometer
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Prominence UFLC

(Date:3/4/2015)... PRC Clinical, a full-service, ... Bay Area, will exhibit and present at the ... on March 25th and 26th in Tel Aviv, Israel. ... Israeli life science companies seeking to conduct U.S. Food ... span all phases of human trials, from Phase I ...
(Date:3/4/2015)... 4, 2015  BioClinica®, Inc., a leading ... today announced that clinical trial professionals representing ... its annual European User Conference in ... the use of its eClinical technologies to ... include: the Microsoft Office-Smart OnPoint CTMS; Express ...
(Date:3/4/2015)... PARIS , March 4, 2015 ... de Paris in December 2011, ... study of yttrium-90 resin microspheres versus sorafenib in advanced ... results expected late 2016.   SARAH, a ... liver cancer (hepatocellular carcinoma, or HCC) has completed patient ...
(Date:3/3/2015)... 2015 /PRNewswire/ - Aptose Biosciences Inc. (NASDAQ: APTO, TSX: ... diagnostics that target the underlying mechanisms of cancer, today ... ended December 31, 2014. Effective July 17, ... May 31 to December 31. As a result of ... for the quarter and the seven months ended December ...
Breaking Biology Technology:PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 2PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 3PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 4BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 2BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 2Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 4Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 2Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 3Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 4Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 7Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 8Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 9Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 10Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 11Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 12
... Osprey Pharmaceuticals U.S.A., a,privately-held company focused on ... leukocytes that are responsible,for initiating and maintaining ... raised $11 million in its first round ... by Burrill & Company with participation from,Novo ...
... NORTH BRUNSWICK, N.J. and NANJING, China, Sept. 3 ... strategic,alliance, combining the drug discovery expertise and project ... medicinal chemistry resources and,favorable cost structure of Acesys ... the alliance will encompass all,aspects of medicinal chemistry ...
... PPHM ) today announced that it will release,its ... 2009 on,September 9, 2008 at 7:00 a.m. EDT and ... results at 11:30 a.m. EDT on the same day., ... the,first quarter ended July 31, 2008 and will review ...
Cached Biology Technology:Osprey Pharmaceuticals U.S.A., Inc. Completes $11 Million Initial Private Financing 2Osprey Pharmaceuticals U.S.A., Inc. Completes $11 Million Initial Private Financing 3Acesys and Provid Announce Alliance for Medicinal Chemistry Services 2Peregrine Pharmaceuticals to Report First Quarter FY 2009 Financial Results 2
(Date:2/12/2015)... Feb. 12, 2015   MedNet Solutions , ... clinical study management systems, has recently bolstered its ... distinguishing iMedNet as the ... (CROs) and healthcare consultants.  Building on the Program,s ... referrals and numerous co-marketing opportunities), MedNet,s new and ...
(Date:2/9/2015)... Feb. 9, 2015  Lintec of America recently announced ... carbon nanotube (CNT) macrostructures, including sheets, yarns and ribbons, ... Leveraging the vast industrial resources of the ... , Lintec of America is forming the Nano-Science ... , focusing on scaling up the manufacturing and ...
(Date:2/5/2015)... OXFORD, Conn. , Jan. 26, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... a new corporate website ( http://www.nxt-id.com/ ) as part ... Wocket™ smart wallet. The Company launched its new consumer ... Gino Pereira , CEO of NXT-ID said, "Our ...
Breaking Biology News(10 mins):MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3
... that it will expand urea deep placement (UDP)a technology that ... hectares (ha) of rice land, reaching about 1.6 million farm ... UDP is the insertion of large urea briquettes into the ... Farmers who use UDP can increase yields by 25% while ...
... of Vanderbilt researchers have demonstrated for the first time ... interference, can heal a genetic disorder in a live ... by the journal Endocrinology, shows that RNA interference can ... engineered to express a defective human hormone that interferes ...
... most successful invasive species in the world, having colonized parts ... South America. A new study sheds light on the secrets ... University of Illinois and the University of California at San ... Academy of Sciences. The Argentine ant is tiny, aggressive ...
Cached Biology News:Bangladesh to dramatically expand technology that doubles efficiency of urea fertilizer use 2RNA interference therapy heals growth deficiency disorder in a live animal 2RNA interference therapy heals growth deficiency disorder in a live animal 3RNA interference therapy heals growth deficiency disorder in a live animal 4Ant invaders eat the natives, then move down the food chain 2